-
effectivehealthcare.ahrq.gov/health-topics/brain-tumors
-
hcup-us.ahrq.gov/reports/methods/2000NISComparisonReportFinal.pdf
February 28, 2003 - The NIS comprised all discharges from a sample of hospitals in this target
universe. … Therefore, we decided to eliminate rehabilitation hospitals from the NIS (and
from the target universe … The overall sampling objective was to select a sample of hospitals that could be generalized to
the target
-
meps.ahrq.gov/data_files/publications/annual_contractor_report/mpc_ann_cntrct_methrpt.pdf
May 01, 2025 - The 2023 MPC cycle target pair-level completion rates were the same as the 2022 goals, with pair
target … The target SBD completion rate goal was 60% of fielded SBD
nodes, which was estimated at baseline to
-
meps.ahrq.gov/data_files/publications/annual_contractor_report/mpc_ann_cntrct_methrpt.shtml
May 01, 2025 - The 2023 MPC cycle target pair‑level completion rates were the same as the 2022 goals, with pair target … The target SBD completion rate goal was 60% of fielded SBD nodes, which was estimated at baseline to
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research-2013.pdf
January 01, 2013 - In addition, populations in selected studies should be similar to the
target population for valid clinical … 4,266
references were retrieved.12 After screening out studies that contained no eligible exposure,
target … The target population was adults with knee pain secondary to knee
osteoarthritis in outpatient settings
-
effectivehealthcare.ahrq.gov/products/headaches-pregnancy/protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
October 01, 2016 - interest (maternal outcomes, childhood
outcomes, adverse events), and within each outcome, by
the target … potentials; WMD = weighted mean difference
Limitations
Within each category of analysis (by outcome, target
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
June 07, 2013 - Peer Reviewer 4 General The target population is hinted at throughout the
document, but an explicit … The key questions are appropriate and clear, as it the
target population.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-200-fullreport.pdf
November 01, 2017 - In the restrictive strategy group, the
transfusion threshold was Hgb < 7g/dL, with a target range after … In
the liberal-strategy group, the transfusion threshold was Hgb <9.5 g/dL, with a target range after
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
March 01, 2012 - used for the basis of our report, have limited inclusion to studies conducted in patients
with the target … Combining studies which report identical outcomes in different target populations
may potentially yield
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
October 01, 2022 - PCI was
associated with lower rates of subsequent target lesion revascularization at 1 year, but not … controlled trial; RR=relative risk; SIHD=stable ischemic heart
disease; SWT=segmental wall thickening; TL=target
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
January 01, 2014 - within excess of the
MIC90 for C. difficile and is consistent with a high level of
activity toward the target
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-health-systems-guidelines-development.pdf
February 01, 2019 - as the perception that the data
were not always tailored to the population or setting that was the target … Each product had the capability to
allow one, but not both, of our target functionality: drill down
-
www.uspreventiveservicestaskforce.org/uspstf/document/decision-analysis-for-aspirin/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
April 11, 2016 - Target Population: Men and women aged 40 to 79 years with a 10-year CVD risk of 20% or less, and no … Target Population
Aspirin for primary prevention was assessed independently for men and women across
-
digital.ahrq.gov/sites/default/files/docs/publication/r21hs018831-czaja-final-report-2013.pdf
January 01, 2013 - group was to solicit
their initial impressions about some software tools that will be modified to target … thumbs up and
thumbs down buttons were modified and button size was increased to provide a larger target
-
www.ahrq.gov/sites/default/files/publications2/files/measure-retirement-2013.pdf
January 01, 2013 - CHIPRA-required reports to
Congress.3 Besides reporting, State Medicaid and CHIP programs could use the data to target … For example, the measure does not target inappropriate antibiotic use and may increase unnecessary testing
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/_SfjkGNHBnLqn8ySe7kAdg
April 01, 2016 - Target Population: Men and women aged 40 to 79 years with
a 10-year CVD risk of 20% or less, and no history … Target Population
Aspirin for primary prevention was assessed inde-
pendently for men and women across
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/473PPVwoRhapCkN9SC-rue
May 18, 2021 - increase was
estimated by the ratio of colorectal cancer incidence (excluding tu-
mors that are not the target … (larger) published estimates5 of the increase in incidence, which
included tumors that are not the target
-
digital.ahrq.gov/sites/default/files/docs/publication/r03hs018830-nemeth-final-report-2013.pdf
January 01, 2013 - Synthesizing Lessons Learned Using Health Information Technology - Final Report
Grant Final Report
Grant ID: R03HS018830
Synthesizing Lessons Learned Using Health
Information Technology
Inclusive Project Dates: 05/01/10 – 04/30/13
Principal Investigator:
Lynne S. Nemeth, PhD, RN
Tea…
-
digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015397-bates-final-report-2008.pdf
January 01, 2008 - Statewide Implementation of Electronic Health Records
Grant Final Report
Grant ID: 5UC1HS015397
Statewide Implementation of Electronic Health Records
Inclusive Dates: 09/30/04 - 09/29/08
Principal Investigator:
David W. Bates, MD, MSc* †
‡
Team Members:
Paul D. Cleary, PhD
Ashish Jha, M…